Literature DB >> 29018983

Nutritional habits, risk, and progression of Parkinson disease.

Roberto Erro1,2, Francesco Brigo3,4, Stefano Tamburin3, Mauro Zamboni5, Angelo Antonini6, Michele Tinazzi3.   

Abstract

Parkinson disease (PD) is a multifactorial disease, where a genetic predisposition combines with putative environmental risk factors. Mounting evidence suggests that the initial PD pathological manifestations may be located in the gut to subsequently affect brain areas. Moreover, several lines of research demonstrated that there are bidirectional connections between the central nervous system and the gut, the "gut-brain axis" that influences both brain and gastrointestinal function. This opens a potential therapeutic window suggesting that specific dietary strategies may interact with the disease process and influence the risk of PD or modify its course. Dietary components can also theoretically modulate the chronic activation of the inflammatory response that is associated with aging, the strongest risk factor for PD, that has been suggested to hasten the underlying neurodegenerative process in PD. Here, we reviewed the evidence supporting an association between certain dietary compound and either the risk or progression of PD and have provided an overview of the possible pathomechanisms linking nutrition and neurodegeneration. The results of our review would not support a clear role for any dietary components in reducing the risk or progression of PD. However, the evidence favouring a connection between gut abnormalities, inflammation, and neurodegeneration in PD have become too compelling to be ignored, so that further research, also in the field of nutritional genomics, is highly warranted.

Entities:  

Keywords:  Diet; Food; Microbiota; Nutraceutic; Nutrition; Parkinson; Risk

Mesh:

Year:  2017        PMID: 29018983     DOI: 10.1007/s00415-017-8639-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  131 in total

1.  The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study.

Authors:  R Erro; M Picillo; C Vitale; M Amboni; M Moccia; G Santangelo; M T Pellecchia; P Barone
Journal:  Eur J Neurol       Date:  2016-07-20       Impact factor: 6.089

2.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

3.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.

Authors:  Kim Tieu; Celine Perier; Casper Caspersen; Peter Teismann; Du-Chu Wu; Shi-Du Yan; Ali Naini; Miquel Vila; Vernice Jackson-Lewis; Ravichandran Ramasamy; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

4.  Vitamin C or Vitamin B6 supplementation prevent the oxidative stress and decrease of prostacyclin generation in homocysteinemic rats.

Authors:  M M Mahfouz; F A Kummerow
Journal:  Int J Biochem Cell Biol       Date:  2004-10       Impact factor: 5.085

5.  Alcohol consumption and the incidence of Parkinson's disease.

Authors:  Miguel A Hernán; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

6.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

7.  Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies.

Authors:  Dongfeng Zhang; Hong Jiang; Junxia Xie
Journal:  Mov Disord       Date:  2014-03-03       Impact factor: 10.338

8.  The efficacy of oral adenosine A(2A) antagonist istradefylline for the treatment of moderate to severe Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Angelo Antonini
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 9.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

10.  Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.

Authors:  Christopher B Forsyth; Kathleen M Shannon; Jeffrey H Kordower; Robin M Voigt; Maliha Shaikh; Jean A Jaglin; Jacob D Estes; Hemraj B Dodiya; Ali Keshavarzian
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

View more
  8 in total

Review 1.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

2.  Prediction of Parkinson's Disease Risk Based on Genetic Profile and Established Risk Factors.

Authors:  Paraskevi P Chairta; Andreas Hadjisavvas; Andrea N Georgiou; Maria A Loizidou; Kristia Yiangou; Christiana A Demetriou; Yiolanda P Christou; Marios Pantziaris; Kyriaki Michailidou; Eleni Zamba-Papanicolaou
Journal:  Genes (Basel)       Date:  2021-08-20       Impact factor: 4.096

Review 3.  Application of Precision Medicine in Neurodegenerative Diseases.

Authors:  Claudia Strafella; Valerio Caputo; Maria R Galota; Stefania Zampatti; Gianluca Marella; Silvestro Mauriello; Raffaella Cascella; Emiliano Giardina
Journal:  Front Neurol       Date:  2018-08-23       Impact factor: 4.003

Review 4.  Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence?

Authors:  Christa Boulos; Nathalie Yaghi; Rita El Hayeck; Gessica Nha Heraoui; Nicole Fakhoury-Sayegh
Journal:  Nutrients       Date:  2019-08-14       Impact factor: 5.717

Review 5.  Diet in Parkinson's Disease: Critical Role for the Microbiome.

Authors:  Aeja Jackson; Christopher B Forsyth; Maliha Shaikh; Robin M Voigt; Phillip A Engen; Vivian Ramirez; Ali Keshavarzian
Journal:  Front Neurol       Date:  2019-12-10       Impact factor: 4.003

6.  Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease.

Authors:  Yogesh Singh; Mohamed El-Hadidi; Jakob Admard; Zinah Wassouf; Julia M Schulze-Hentrich; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Daniel Huson; Olaf Riess; Nicolas Casadei
Journal:  Front Neurosci       Date:  2019-10-15       Impact factor: 4.677

Review 7.  Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration.

Authors:  Francesco Gentile; Pietro Emiliano Doneddu; Nilo Riva; Eduardo Nobile-Orazio; Angelo Quattrini
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

Review 8.  Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson's Disease.

Authors:  Anaıs Marie; Morgane Darricau; Katia Touyarot; Louise C Parr-Brownlie; Clémentine Bosch-Bouju
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.